The Commercialization of Umbilical Cord Blood Banking in China and its Operational Challenges

Albert Chen of China Cord Blood Corporation  joined us last year at Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘The Commercialization of Umbilical Cord Blood Banking in China and its Operational Challenges .’ Download his presentation now in order to understand more about: CCBC Overview Regulatory Overview Sales and Marketing Operational Challenges …and much more! Get your copy here!  …

Pharmaceutical executives challenges

The Transformation Challenges Facing Pharmaceutical Executives

Pharmaceutical companies across the globe face unprecedented challenges as revenue streams come under pressure. This is a consequence of pricing pressures caused by healthcare reforms and government austerity measures. At the same time, companies face increased competition and the difficulty of bringing new drugs and products to market. They have to embrace technological innovation and look at cross-industry best practices …

IP, Pharma, Generics, Opportunities, Challenges, Europe,

IP in Pharma Generics Opportunities & Challenges in the EU

At the World Generic Medicines Congress Europe 2014, Thomas Kolzau, Helm AG, gave a presentation entitled “IP in Pharma Generics Opportunities & Challenges in the EU” Download and learn: Opportunities – pharma generics Challenges – pharma generics Oppositions in the generic market Appeals in the generic market Settlement Manufacturing & stockpiling Importance of the EU generics industry Impact of a manufacturing …

Download ebook: Why clinical trials fail and what we can do about it

    The challenges that the pharmaceutical industry faces in launching a drug are plentiful and well documented. From the cost of R&D, high failure rate, ever toughening reimbursement requirements and ever growing competition. One significant element of getting a product approved is a successful clinical trials. It is an exciting time for the industry as there are signs of …

Download ebook: Top challenges in HTA

    In today's austere times, payers are continuing to control escalating healthcare costs, relying on health technology assessment agencies in order to make purchasing decisions and effective use of funds.  HTA is an important part of evidence-based health decision-making in most EU countries with ever increasing demands for value demonstration proving your drugs are most beneficial to patients. This …

Download Ebook: Top 5 biggest challenges in Pharma compliance

The increasing number of transparency regulations in Pharma and anti-corruption & anti-bribery laws are beginning to resemble legislation in the United States. The risk of severe fines and a tarnished reputation means companies need to make sure they are managing risk and implementing a comprehensive compliance programme. But what are the key challenges faced by compliance professionals in pharma? From …

Challenges and opportunities in the treatment of rare diseases

Rare diseases affect more than 55 millions patients in US and EU alone, highlighting the huge societal impact of these diseases.  The various clinical, regulatory and commercial challenges to develop treatment for these diseases call for actions from various parties involved.  One of the successful initiatives is the orphan drug legislation by FDA in US.  Prior to the Orphan Drug …